Neural Basis of Decision-Making Deficits in Traumatic Brain Injury

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 18, 2014

Primary Completion Date

February 13, 2024

Study Completion Date

February 13, 2024

Conditions
Traumatic Brain Injury
Interventions
DEVICE

tDCS

There is no study intervention for Experiment 1. The study intervention for Experiment 2 is tDCS. tDCS is a non-invasive brain stimulation technique that uses electrodes attached to the scalp to deliver very low intensity direct current to the brain. This intervention has been demonstrated to result in neuromodulatory effects.

DRUG

[11C] Raclopride

\[11C\] Raclopride is administered under an IND 054135. This IND is sponsored by the NIH Clinical Center and \[11C\] Raclopride is dispensed by the NIH PET Department. Quality Assurance for Radioactive Drug: \[11C\] Raclopride, is assayed for radiochemical purity under the supervision of the NIH PET Department prior to dispensing the drug for administration. Given that IND PET drugs manufactured at the NIH PET Department are used in a single site and that there is no intent for their commercialization, submission of IBs has not been required by FDA for any of the NIH Office of Research Support and Compliance-sponsored IND applications.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
collaborator

Uniformed Services University of the Health Sciences

FED

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT02169310 - Neural Basis of Decision-Making Deficits in Traumatic Brain Injury | Biotech Hunter | Biotech Hunter